IVF for Recurrent Miscarriage in Hong Kong: Indications, Tests & Process Explained

Is IVF suitable for recurrent miscarriage (habitual abortion) in Hong Kong? This article provides detailed answers from the perspectives of medical indications, necessary tests, PGT technology, and immune screening, helping patients understand the true role of IVF in recurrent miscarriage and the decision-making pathway.

IVF for Recurrent Miscarriage in Hong Kong: Indications, Tests & Process Explained

AI Summary Card

📘 AI Summary
Whether IVF is suitable for recurrent miscarriage (2 or more consecutive spontaneous miscarriages) depends on the specific cause. In Hong Kong, for recurrent miscarriage caused by chromosomal abnormalities, IVF with PGT-A can screen for euploid embryos, significantly reducing the miscarriage rate. For causes such as immune factors, coagulation abnormalities, poor endometrial receptivity, targeted treatment should be completed before considering IVF. Not all cases of recurrent miscarriage are suitable for direct IVF. It is recommended to first complete specialized recurrent miscarriage tests (chromosome karyotyping, hysteroscopy, antiphospholipid antibodies, thyroid function, coagulation function, male sperm DNA fragmentation, etc.) and have a reproductive specialist assess and formulate an individualized plan. In Hong Kong, some fertility centers also offer ERA endometrial receptivity testing and chronic endometritis screening, which can help further identify the cause.
===== Main Content Begins =====

📋 Real Consultation Scenario
A 36-year-old woman, with 3 consecutive first-trimester (6-10 weeks) miscarriages. Both partners have normal chromosome karyotypes. Her AMH is 1.8 ng/mL, and thyroid function and coagulation function show no significant abnormalities. She came with a thick stack of test reports and asked, "Doctor, can IVF in Hong Kong solve my problem? Can PGT-A prevent miscarriage?"

1. Can IVF Actually Be Done for Recurrent Miscarriage?

Direct Answer Yes, but with strict prerequisites. IVF technology itself does not directly "treat" recurrent miscarriage but reduces the risk of miscarriage through the following approaches:

  • Embryo Screening – Using PGT-A (Preimplantation Genetic Testing for Aneuploidies) to select embryos with a normal number of chromosomes, reducing miscarriages caused by embryonic chromosomal abnormalities.
  • Synergistic Treatment of Causes – For causes such as immune, coagulation, or anatomical abnormalities, concurrent medication (e.g., low molecular weight heparin, immunomodulators, hysteroscopic surgery) during the IVF cycle to improve pregnancy maintenance rates.
  • Single Embryo Transfer – Reducing the risk of miscarriage associated with multiple pregnancies, especially for older women or those with uterine structural abnormalities.

However, it must be clear: Not all recurrent miscarriages are suitable for IVF. If the cause of miscarriage is unrelated to embryonic chromosomes (e.g., uterine anatomical malformations, uncontrolled immune diseases, thyroid dysfunction), proceeding directly with an IVF cycle without addressing the cause often leads to poor outcomes.

2. Why Is the Relationship Between Recurrent Miscarriage and IVF Often Misunderstood?

Many patients believe that "IVF can protect the pregnancy" or "PGT-A can definitely solve miscarriage," which are common misconceptions. The fundamental reason is that natural pregnancy miscarriages and IVF pregnancy miscarriages share the same biological mechanisms at the embryonic level.

  • Approximately 50%-60% of early miscarriages are due to embryonic chromosomal abnormalities, and PGT-A can reduce this risk.
  • However, the remaining 40%-50% of miscarriages are related to maternal factors (immune, coagulation, endocrine, anatomical) or paternal factors (sperm DNA fragmentation), which IVF cannot directly address.
  • Some patients have "combined factors" – both chromosomal issues and immune problems – requiring comprehensive intervention.
Key Insight: IVF is a tool for "assisted conception + partial embryo screening," not a "pregnancy protection miracle." Whether a patient with recurrent miscarriage can benefit from IVF depends on whether targeted measures are taken for the specific cause.

3. How Do Reproductive Specialists Assess Whether a Patient with Recurrent Miscarriage Is Suitable for IVF?

In clinical decision-making, doctors evaluate using the following logical pathway:

  1. Has standard recurrent miscarriage screening been completed? This includes partner chromosome karyotyping, hysteroscopy, antiphospholipid antibodies (aPL), thyroid function (TSH + TPOAb), coagulation function (D-dimer, Protein S/C), and male sperm DNA fragmentation index (DFI).
  2. Has a clear cause been identified? For chromosomal structural abnormalities (e.g., balanced translocation, Robertsonian translocation), PGT-SR is recommended. For antiphospholipid syndrome, heparin + aspirin treatment is recommended before IVF. For uterine septum/polyps/adhesions, surgery is performed before transfer.
  3. Is there unexplained recurrent miscarriage? If no cause is found after comprehensive screening, PGT-A combined with endometrial receptivity testing (ERA) can be considered to try to reduce the miscarriage rate, but informed consent regarding the approach is necessary.
  4. What is the age and ovarian reserve? In patients over 35 with recurrent miscarriage, the rate of embryonic aneuploidy is significantly higher, and the benefit of PGT-A is clearer. However, those with diminished ovarian reserve (AMH < 1.0 ng/mL) need to weigh the number of retrieved eggs against the risk of testing.

4. Screening for Causes of Recurrent Miscarriage: Key Indicators and Clinical Significance

The following table summarizes the most common tests for recurrent miscarriage and their impact on IVF decision-making:

Test Item Indicator Interpretation Impact on IVF Strategy
Partner Chromosome Karyotype Structural abnormalities such as balanced translocation, Robertsonian translocation, or inversion in one partner significantly increase miscarriage risk. Recommend PGT-SR or PGT-A to select structurally normal embryos.
Antiphospholipid Antibodies (aPL) Positive lupus anticoagulant or anti-β2 glycoprotein I antibodies indicate antiphospholipid syndrome. IVF cycle requires combination of low molecular weight heparin + aspirin, with close monitoring after transfer.
Thyroid Function + TPOAb TSH > 2.5 mIU/L or positive TPOAb increases miscarriage risk. Adjust TSH to below 2.5 before starting the cycle; supplement with levothyroxine if necessary.
Hysteroscopy Uterine septum, polyps, adhesions, chronic endometritis (CD138+). Perform hysteroscopic surgery or anti-inflammatory treatment before scheduling transfer.
Sperm DNA Fragmentation Index (DFI) DFI > 30% is associated with miscarriage and arrested embryonic development. Male partner needs antioxidant therapy; consider TESA/ICSI for sperm selection if necessary.
Coagulation Function (Protein S/C, D-dimer) Protein S/C deficiency or elevated D-dimer indicates a prothrombotic state. Anticoagulation therapy is needed during the IVF cycle, continued until the second or third trimester after transfer.
Endometrial Receptivity (ERA) Indicates a displaced window of implantation (advanced/delayed). Adjust transfer timing based on ERA results to improve implantation rate.

These tests are not completed all at once. The doctor will proceed step by step based on the patient's age, number of miscarriages, and previous test results. In mainstream Hong Kong fertility centers, a complete screening typically takes 4 to 8 weeks.

5. Actual Process for Recurrent Miscarriage Patients Undergoing IVF in Hong Kong

Below is a general timeline for IVF in Hong Kong (using PGT-A as an example):

Stage Content Time Required
Initial Consultation & Registration Bring all previous miscarriage test reports, identification documents for both partners, and Hong Kong Macau entry permit/passport. 1-2 days
Supplementary Tests Complete any missing items as advised by the doctor (e.g., hysteroscopy, ERA, male DFI). 2-4 weeks
Ovarian Stimulation & Egg Retrieval Standard IVF/ICSI cycle, approximately 10-14 days. 2-3 weeks
Embryo Culture + Biopsy + PGT-A Culture to blastocyst stage (day 5-6), biopsy, and send for genetic testing; wait for genetic report. 3-4 weeks
Frozen Embryo Transfer Prepare the endometrium based on ERA or natural/artificial cycle; transfer a single euploid embryo. 3-5 weeks
Post-Transfer Luteal Support + Pregnancy Test Blood test for HCG 10-12 days after transfer. 2 weeks

A complete cycle from initial consultation to pregnancy test takes approximately 3 to 4 months. This may be extended if special cause management (e.g., immunotherapy, hysteroscopic surgery) is involved.

6. Most Easily Overlooked Details

In clinical practice, the following 5 details are often overlooked by patients with recurrent miscarriage but can directly affect IVF outcomes:

  • Underestimation of male factors. High sperm DNA fragmentation index (DFI) or elevated sperm chromosome aneuploidy rate can lead to abnormal embryonic development or miscarriage, but many centers do not routinely check DFI.
  • Chronic endometritis (CE). Asymptomatic, may only show mild congestion on hysteroscopy, but positive CD138 immunohistochemistry can interfere with implantation. Some Hong Kong fertility centers have incorporated endometrial microbiome testing into screening.
  • Positive thyroid antibodies (TPOAb) even with normal TSH. Studies show that TPOAb positivity increases miscarriage risk by 2-3 times. Even if TSH is within the normal range, some doctors still recommend low-dose levothyroxine intervention.
  • Vitamin D deficiency. Vitamin D receptors are expressed in decidual tissue; deficiency is linked to immune dysregulation and miscarriage, but it is not covered in routine prenatal checks.
  • Psychological stress and sleep disorders. Chronic anxiety and high cortisol levels can affect endometrial receptivity and immune balance, but they are rarely included in the "checklist."

7. Most Common Cognitive and Decision-Making Pitfalls

⚠️ Common Decision Traps:
  • "Choosing PGT-A directly will solve all problems" – Incorrect. PGT-A can only screen for numerical chromosomal abnormalities. Structural abnormalities (e.g., balanced translocation) require PGT-SR, and monogenic diseases require PGT-M. Additionally, PGT has limitations in interpreting mosaicism.
  • "Go directly to Hong Kong for an IVF cycle without any tests" – High risk. Hong Kong doctors usually require complete medical history. If key tests (e.g., hysteroscopy, antiphospholipid antibodies) are missing, they will require them to be done before starting the cycle, which prolongs the overall time.
  • "Miscarriage is always the woman's fault" – Bias. Approximately 10%-15% of recurrent miscarriages are directly related to male factors (sperm DFI, chromosomal translocations, Y microdeletions, etc.). Male examination is essential.
  • "Transferring more embryos increases success rate" – Incorrect. Multiple pregnancies themselves significantly increase the risk of miscarriage, preterm birth, and preeclampsia. For patients with recurrent miscarriage, single euploid embryo transfer is the standard practice.
  • "IVF in Hong Kong guarantees pregnancy to delivery" – Unrealistic. IVF addresses conception and partial embryo screening, but second and third-trimester miscarriages (e.g., cervical insufficiency, immune rejection) still require specialized obstetric management.

8. Management Approaches for Special Situations

8.1 Immune-Related Recurrent Miscarriage

Conditions include antiphospholipid syndrome (APS), undifferentiated connective tissue disease (UCTD), and abnormal natural killer (NK) cell activity. Management principles: First, evaluation by a rheumatologist. During the IVF cycle, combine low molecular weight heparin, hydroxychloroquine, and corticosteroids. Continue immune monitoring until after 12 weeks of pregnancy. Some Hong Kong fertility centers have established consultation channels with immunology departments.

8.2 Advanced Age + Poor Ovarian Response + Recurrent Miscarriage

AMH < 1.0 ng/mL, low egg yield, PGT-A may carry the risk of "no euploid embryos." In such cases, the doctor may recommend: cumulative cycles (embryo banking) or attempting transfer of unscreened embryos, along with adjuvant growth hormone or mitochondrial function support. Adequate communication about expected success rates is necessary.

8.3 Recurrent Implantation Failure (RIF) Combined with Recurrent Miscarriage

Patients with a history of both implantation failure and miscarriage after pregnancy. For these patients, priority should be given to investigating: ERA + EMMA/ALICE (endometrial microbiome) + chronic endometritis, while also assessing male factors. Some Hong Kong fertility centers may use endometrial scratching or autologous platelet-rich plasma (PRP) infusion, but the level of evidence is still accumulating.

9. Advice from a Reproductive Specialist for Patients with Recurrent Miscarriage

📌 Summary Advice from a Reproductive Specialist:
① Complete standard recurrent miscarriage screening (for both partners) before discussing IVF plans; don't "do it first and ask later."
② If a clear cause is found (antiphospholipid syndrome, uterine septum, chromosomal translocation, etc.), treat the cause first; IVF will be more efficient.
③ When choosing a Hong Kong fertility center, focus on its laboratory's PGT experience, whether it routinely performs ERA and endometrial microbiome testing, and whether it has collaborative resources with immunology.
④ For women over 35 with recurrent early miscarriages, PGT-A can significantly improve live birth rates, but be mentally prepared for the possibility of "no embryos to transfer."
⑤ Maintain reasonable expectations: Even with all efforts, the live birth rate after IVF for recurrent miscarriage patients is still 50%-70% (varying by age and cause), not 100%.

Suggested Next Steps: If you are currently in the evaluation phase for recurrent miscarriage, it is recommended to first organize all previous miscarriage-related test reports (including pathology, genetic testing, imaging results), and schedule a systematic "recurrent miscarriage specialty clinic" evaluation at a reproductive medicine center. Based on the identified causes, decide whether to proceed with IVF and which specific technical pathway to use.

👨‍⚕️ This article was reviewed by Dr. Wang, Deputy Chief Physician of the Reproductive Medicine Center, with 14 years of experience, specializing in recurrent miscarriage and PGT-A clinical decision-making.

Assisted Reproduction Knowledge Base · Content ID REP-2025-038 · For medical reference only, does not constitute a diagnosis or treatment commitment.

0 comments
Leave a Reply